Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Skin-to-Skin cuddles may shield preemie brains from bleeding

NCT ID NCT07473882

Prevention Sponsor: Hospital Universitario 12 de Octubre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether kangaroo care (skin-to-skin contact with a parent) can reduce the risk of severe brain bleeding in extremely preterm newborns. About 314 babies born at 28 weeks or earlier will be randomly placed in a side-lying kangaroo position, a prone kangaroo position, or standard incubator care. The main goal is to see if the side-lying position lowers the chance of severe intraventricular hemorrhage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
kangaroo care (skin-to-skin contact) in side-lying or prone position
What this could lead to
If it works, this could point toward a simple, low-cost way to protect extremely premature babies from severe brain bleeding.
What could go wrong
This trial hasn't started yet and is relatively small (314 babies). The results may not apply to all preterm infants, and kangaroo care must be done carefully to avoid other risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 314 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 minute to 72 hours

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm infants born at 28 weeks of gestational age or less, admitted to the NICU and born at the study center (inborn), less than 72 hours old, with a parent or legal guardian present who is willing to provide kangaroo care. Exclusion Criteria: * Preterm infants in the immediate postoperative period following major surgery. * Preterm infants with congenital abdominal wall malformations. * Preterm infants requiring immobilization. * Preterm infants who are clinically unstable and unable to tolerate kangaroo care. * Preterm infants whose parents decline participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ivh- intraventricular hemorrhage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ivh- intraventricular hemorrhage Kangaroo care Premature infant

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Universitario 12 de Octubre

    Madrid, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.